Last reviewed · How we verify
Seasonal,quadrivalent,influenza vaccine
Seasonal,quadrivalent,influenza vaccine is a Small molecule drug developed by University Hospital, Ghent. It is currently FDA-approved. Also known as: Alfa-Rix Tetra 2016-2017.
At a glance
| Generic name | Seasonal,quadrivalent,influenza vaccine |
|---|---|
| Also known as | Alfa-Rix Tetra 2016-2017 |
| Sponsor | University Hospital, Ghent |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Phase 3 Study to Evaluate the Immunogenicity and Safety of Inactived Split Influenza Vaccine in Healthy Korea Infants (PHASE3)
- A Study to Evaluate the Safety and Immunogenicity of Two Doses of DCVC H1 HA mRNA-LNP in Healthy Adults (PHASE1)
- A Study of Modified mRNA Vaccines in Healthy Adults (PHASE1)
- A Study to Find the Dose and Assess the Immune Response and Safety of a Vaccine Against Influenza in Healthy Younger and Older Adults (PHASE2)
- Intralesional Influenza Vaccine for the Treatment of Stage I-IV Melanoma (PHASE1)
- Long-term Safety, Tolerability and Effectiveness Study of Ofatumumab in Patients With Relapsing MS (PHASE3)
- Evaluation of Human Immune Responses Vaccination in Patients With Lymphoma
- Characterization of Humoral and Cellular Immune Responses Elicited by Influenza Vaccination in Healthy Adults (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Seasonal,quadrivalent,influenza vaccine CI brief — competitive landscape report
- Seasonal,quadrivalent,influenza vaccine updates RSS · CI watch RSS
- University Hospital, Ghent portfolio CI
Frequently asked questions about Seasonal,quadrivalent,influenza vaccine
What is Seasonal,quadrivalent,influenza vaccine?
Seasonal,quadrivalent,influenza vaccine is a Small molecule drug developed by University Hospital, Ghent.
Who makes Seasonal,quadrivalent,influenza vaccine?
Seasonal,quadrivalent,influenza vaccine is developed and marketed by University Hospital, Ghent (see full University Hospital, Ghent pipeline at /company/university-hospital-ghent).
Is Seasonal,quadrivalent,influenza vaccine also known as anything else?
Seasonal,quadrivalent,influenza vaccine is also known as Alfa-Rix Tetra 2016-2017.
What development phase is Seasonal,quadrivalent,influenza vaccine in?
Seasonal,quadrivalent,influenza vaccine is FDA-approved (marketed).
Related
- Manufacturer: University Hospital, Ghent — full pipeline
- Also known as: Alfa-Rix Tetra 2016-2017
- Compare: Seasonal,quadrivalent,influenza vaccine vs similar drugs
- Pricing: Seasonal,quadrivalent,influenza vaccine cost, discount & access